Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
$ 189.1MEnterprise Value
VS
Market
Sector
Industry
History
$ 2.54Close
$ 1.18 - $ 11.68 52-Week Range
Ticker Information
Ticker
BTAICompany Name
BIOXCEL THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQBIOXCEL THERAPEUTICS INC - Enterprise Value Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
BTAI - EV Historical data
| Date | Cash and Equivalents | Total Debt | Enterprise Value | Market Capitalization |
|---|---|---|---|---|
| 6/30/2025 | $ 18.57M | $ 108.69M | $ 189.1M | $ 98.99M |
| 3/31/2025 | $ 31.01M | $ 105.53M | $ 83.48M | $ 8.96M |
| 12/31/2024 | $ 29.85M | $ 102.57M | $ 84.35M | $ 11.63M |
| 9/30/2024 | $ 40.39M | $ 104.6M | $ 86.46M | $ 22.25M |
| 6/30/2024 | $ 56.27M | $ 103.26M | $ 86.11M | $ 39.11M |
| 3/31/2024 | $ 74.14M | $ 101.98M | $ 114.35M | $ 86.51M |
| 12/31/2023 | $ 65.22M | $ 101.04M | $ 121.74M | $ 85.92M |
| 9/30/2023 | $ 89.96M | $ 99.62M | $ 133.19M | $ 123.53M |
| 6/30/2023 | $ 127.55M | $ 97.46M | $ 96.64M | $ 126.73M |
| 3/31/2023 | $ 165.52M | $ 95.77M | $ 725.14M | $ 794.89M |
Key Performance Insights, Last 5 Years
- BIOXCEL THERAPEUTICS INC's latest trailing twelve months (TTM) EV stands at $ 1.11B.
- Over the past 5 years, BIOXCEL THERAPEUTICS INC's average EV has been $ 343.33M.
- The median EV for BIOXCEL THERAPEUTICS INC during this period was $ 220.93M
- BIOXCEL THERAPEUTICS INC reached its highest EV over the past 5 years at $ 1.11B.
- The lowest EV recorded by BIOXCEL THERAPEUTICS INC in the same timeframe $ 83.48M
BIOXCEL THERAPEUTICS INC's EV vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
EV Benchmarks
Similar metrics to Market Cap:
- Enterprise Value over EBIT - [Calculation] Measures a company’s Enterprise Value [EV] in relation to its earnings before interest and taxes [EBIT].
- Enterprise Value over EBITDA - [Calculation] Measures a company’s Enterprise Value [EV] in relation to its earnings before interest, taxes, depreciation, and amortization [EBITDA].
- Enterprise Value over Free Cash Flow - [Calculation] Measures a company’s Enterprise Value [EV] in relation to its Free Cash Flow [FCF].
- Debt Paydown Yield - [Calculation] The Debt Paydown Yield measures the net change in longterm [Debt] divided by the company’s [MarketCap]. A high debt pay down yield indicates that the business is aggressively paying down debt which increases shareholder [Equity].
- Free Cash Flow Yield - [Calculation] The Free Cash Flow Yield, also known as the inverse of the Price to Free Cash Flow ratio [PFCF], expresses a company’s Free Cash Flow [FCF] as a percentage of [MarketCap.
Definition of Enterprise Value
[Calculation] Enterprise value (EV) refers to the total value of a business and is frequently used as a more elaborate substitute for market capitalization. EV is calculated as a company's [MarketCap] plus its [Debt] minus cash and cash equivalents [CashnEq].Market Cap + Debt - CashnEq
(=) EV EV for BIOXCEL THERAPEUTICS INC is calculated as follows: Market Cap [ $ 1.34B ] + Debt [ $ 1.47M ] - CashnEq [ $ 233.43M ]
(=) EV [ $ 1.11B ] BTAI - Enterprise Value, Last 5 years
$ 83.48M
Minimum
Mar 31, 2025
$ 1.11B
Maximum
Sep 30, 2020
$ 343.33M
Average
$ 220.93M
Median
EV Benchmark AnalysisMarket
The chart above depicts the distribution of EV for companies in the Total Stock Market. The average EV of the companies is $ 1.25B with a standard deviation of $ 1.67B.
The following table provides additional summary stats:
EV in the Market:
| filtered constituents | 3.32K |
|---|---|
| min | $ -1.69B |
| max | $ 6.88B |
| average | $ 1.25B |
| median | $ 439.6M |
| std | $ 1.67B |